Diagnostic Criteria for Cardiogenic Shock

Clinical Diagnostic Criteria

• The American College of Cardiology recommends that cardiogenic shock diagnosis requires BOTH sustained hypotension (systolic BP <90 mmHg for >30 minutes OR mean arterial pressure <60 mmHg OR need for vasopressors to maintain these thresholds) AND clinical evidence of end-organ hypoperfusion—hypotension alone is insufficient for diagnosis 1, 2, 3
• The American College of Cardiology states that the diagnosis mandates meeting both components simultaneously, including hypotension and clinical evidence of end-organ hypoperfusion 1, 2
• Systolic BP <90 mmHg sustained for >30 minutes is a criterion for hypotension, as recommended by the American College of Cardiology 1, 2, 3
• Mean arterial pressure <60 mmHg for >30 minutes is another criterion for hypotension, according to the American College of Cardiology 1, 2
• Requirement of vasopressors to maintain systolic BP ≥90 mmHg or MAP ≥60 mmHg is also a criterion for hypotension, as stated by the American College of Cardiology 1, 2
• Decreased mentation/altered mental status is a sign of end-organ hypoperfusion, as noted by the American College of Cardiology 1, 2, 3
• Cold extremities with livedo reticularis is another sign of end-organ hypoperfusion, according to the American College of Cardiology 1, 2
• Urine output <30 mL/hour is a sign of end-organ hypoperfusion, as recommended by the American College of Cardiology and the European Heart Journal 1, 2, 4
• Lactate >2 mmol/L is a sign of end-organ hypoperfusion, according to the American College of Cardiology and the European Heart Journal 1, 2, 4
• Metabolic acidosis is a sign of end-organ hypoperfusion, as noted by the European Heart Journal 4
• Mixed venous oxygen saturation (SvO₂) <65% is a sign of end-organ hypoperfusion, according to the European Heart Journal 4

Hemodynamic Diagnostic Criteria

• The American College of Cardiology recommends that cardiogenic shock diagnosis requires ALL three core parameters (cardiac index <2.2 L/min/m², pulmonary capillary wedge pressure (PCWP) >15 mmHg, and systolic BP <90 mmHg) plus systolic BP <90 mmHg when invasive monitoring is available 1, 2
• Cardiac index <2.2 L/min/m² is a core hemodynamic parameter for cardiogenic shock diagnosis, as stated by the American College of Cardiology and Circulation 1, 2, 3
• Pulmonary capillary wedge pressure (PCWP) >15 mmHg is another core hemodynamic parameter for cardiogenic shock diagnosis, according to the American College of Cardiology and Circulation 1, 2, 3
• Systolic BP <90 mmHg or mean BP <60 mmHg is a criterion for hypotension, as recommended by the American College of Cardiology 1, 2
• Cardiac power output <0.6 W is a supportive hemodynamic marker for cardiogenic shock diagnosis, as noted by the American College of Cardiology 1, 2
• Shock index >1.0 is another supportive hemodynamic marker for cardiogenic shock diagnosis, according to the American College of Cardiology 1, 2
• Central venous pressure >15 mmHg is a supportive hemodynamic marker for cardiogenic shock diagnosis, as stated by the American College of Cardiology 1, 5

SCAI Staging Classification

• The Society for Cardiovascular Angiography and Interventions provides a five-stage system for risk stratification, including Stage A (At Risk), Stage B (Beginning Shock/"Pre-shock"), Stage C (Classic Cardiogenic Shock), Stage D (Deteriorating), and Stage E (Extremis) 1, 2, 5
• Stage A (At Risk) is characterized by normal hemodynamics, normotensive (SBP >100 mmHg), normal perfusion, and warm extremities, as recommended by the American College of Cardiology 1, 2
• Stage B (Beginning Shock/"Pre-shock") is characterized by elevated venous pressure, hypotension (SBP <90 mmHg, MAP <60 mmHg, or >30 mmHg drop from baseline), and normal perfusion still present with warm extremities, according to the American College of Cardiology 1, 2
• Stage C (Classic Cardiogenic Shock) is characterized by elevated venous pressure, hypotension, hypoperfusion present, cold/ashen extremities with livedo, weak or nonpalpable pulses, altered mentation, decreased urine output, and respiratory distress, as noted by the American College of Cardiology 1, 2
• Stage D (Deteriorating) is characterized by same as Stage C but worsening despite escalating vasopressors or mechanical circulatory support, according to the American College of Cardiology 1, 2
• Stage E (Extremis) is characterized by cardiac arrest, refractory hypotension/hypoperfusion requiring CPR, pulseless electrical activity (PEA), recurrent ventricular tachycardia/fibrillation, and SBP only maintained with resuscitation, as recommended by the American College of Cardiology 1, 2

Critical Diagnostic Pitfalls

• Hypotension is the primary clinical manifestation but insufficient for diagnosis without evidence of end-organ hypoperfusion, as noted by the American College of Cardiology and Circulation 2, 3
• Always assess for clinical signs: mental status changes, cold extremities, oliguria, elevated lactate, as recommended by the American College of Cardiology 1, 2
• Cardiogenic shock is distinguished from other shock types by elevated PCWP (>15 mmHg), elevated CVP, elevated systemic vascular resistance, as stated by the American College of Cardiology and Praxis Medical Insights 1, 5
• Hypovolemic shock is characterized by low PCWP (<15 mmHg), low CVP, cold extremities but responds to fluid challenge, according to Praxis Medical Insights 6
• Distributive shock is characterized by low systemic vascular resistance, normal or increased cardiac output initially, warm extremities, as noted by Praxis Medical Insights 5

Immediate Assessment Requirements

• When cardiogenic shock is suspected, an ECG should be performed immediately to identify acute coronary syndrome, as recommended by the European Heart Journal 4
• Ech

Cardiac Power Output (CPO) – Definition, Calculation, and Clinical Thresholds

Definition and Critical Thresholds

• The American College of Cardiology defines cardiac power output as (cardiac output [L/min] × mean arterial pressure [mmHg]) ÷ 451, yielding watts; normal resting CPO in healthy adults is approximately 0.9–1.1 W, and a value < 0.6 W identifies refractory cardiogenic shock that warrants mechanical circulatory support. 7

Formula and Physiologic Rationale

• Standard CPO formula: CPO (W) = (Cardiac Output [L/min] × Mean Arterial Pressure [mmHg]) ÷ 451. This equation integrates both the flow (CO) and pressure (MAP) domains of the cardiovascular system, providing a more comprehensive assessment of cardiac pumping ability than either parameter alone. 7, 8

• The integrative nature of CPO surpasses the prognostic value of isolated cardiac output or MAP, because it reflects the combined capacity to generate flow and pressure. 7

Hemodynamic Measurement for CPO Calculation

• In patients with suspected cardiogenic shock, the American College of Cardiology recommends obtaining invasive hemodynamics via a pulmonary artery catheter, measuring cardiac output by thermodilution or the Fick method and recording mean arterial pressure simultaneously. These measurements are required to compute CPO accurately. 7

• Once CO and MAP are measured, clinicians should calculate CPO using the standard formula (CO × MAP ÷ 451) to assess shock severity and guide therapeutic escalation. 7, 8

Hemodynamic Diagnostic Criteria for Cardiogenic Shock

Core Hemodynamic Parameters

• The American College of Cardiology (ACC) guideline states that cardiogenic shock is diagnosed only when systolic blood pressure < 90 mm Hg for > 30 minutes (or requiring vasopressors), cardiac index < 2.2 L/min/m² (or < 1.8 L/min/m² without inotropic/vasopressor support), and pulmonary capillary wedge pressure > 15 mm Hg are present simultaneously【9】.
• A cardiac index < 2.2 L/min/m² is the primary marker of impaired pump function; values < 1.8 L/min/m² without pharmacologic support define severe cardiogenic shock【9】.
• Pulmonary capillary wedge pressure > 15 mm Hg (often > 18‑20 mm Hg in classic cases) reflects left‑ventricular failure and is required to differentiate cardiogenic shock from hypovolemic shock, which shows low PCWP【9】.

Clinical Signs of End‑Organ Hypoperfusion

• In addition to hypotension, at least one sign of hypoperfusion must be documented (e.g., altered mental status, cold extremities, urine output < 30 mL/h, lactate > 2 mmol/L) to meet the ACC definition of cardiogenic shock【9】.

Severity Staging (SCAI)

• A systolic blood pressure of 130 mm Hg does not meet the shock criteria and places the patient in SCAI Stage A (at‑risk) despite any other findings【9】【10】.
• Sustained SBP < 90 mm Hg together with hypoperfusion signs corresponds to SCAI Stage C (classic cardiogenic shock)【9】【10】.

Diagnostic Algorithm (ACC 2022)

• Cardiac index < 2.2 L/min/m²【9】
• PCWP > 15 mm Hg【9】
• Cardiac power output < 0.6 W (calculated as CO × MAP ÷ 451) signals refractory shock and prompts consideration of mechanical circulatory support【9】.

Key Pitfalls (ACC 2022)

• Hypotension alone is insufficient for a cardiogenic shock diagnosis; both low blood pressure and objective hypoperfusion must coexist【9】.
• Elevated filling pressures (PCWP > 15 mm Hg and elevated central venous pressure) uniquely identify cardiogenic shock, whereas hypovolemic shock shows low filling pressures and distributive shock shows low systemic vascular resistance with normal or high cardiac output【9】.
• A systolic blood pressure of 130 mm Hg categorically excludes cardiogenic shock, regardless of other hemodynamic or clinical findings【9】.